Studies on the mechanism of inflammation induced by calcium pyrophosphate crystals.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001168:Arthritis / Q000139:chemically induced / Q000276:immunology; D003169:Complement Inactivator Proteins; D003460:Crystallization; D011756:Diphosphates / Q000008:administration & dosage; D007249:Inflammation / Q000139:chemically induced* / Q000276:immunology; D007270:Injections, Intra-Articular; D007279:Injections, Subcutaneous; D007962:Leukocytes / Q000187:drug effects; D008247:Lysosomes / Q000201:enzymology; D011480:Protease Inhibitors; D011817:Rabbits; D012871:Skin Diseases / Q000139:chemically induced / Q000276:immunology; D013583:Synovial Membrane; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014688:Venoms / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D000614:Aminocaproates; D003169:Complement Inactivator Proteins; D011756:Diphosphates; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D014688:Venoms; D014747:Vinblastine; D007611:Aprotinin